Feltsense | $5,100,000 | (Feb 5, 2026)
Stratus Medical | $10,000,000 | (Feb 5, 2026)
beHuman Corp. | $4,000,000 | (Feb 5, 2026)
Certified by Founder
Lodge
Koneksa
start up
United States
- New York
- 08/02/2022
- Series C
- $45,000,000
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research.
- Industry Pharmaceutical Manufacturing
- Website http://www.koneksahealth.com/
- LinkedIn https://www.linkedin.com/company/koneksa-health/
Related People
Chris BenkoFounder
United States -
New York, New York
NA
LinkedIn
https://www.linkedin.com/in/cbenko/
Boomband | $4,000,000 | (Feb 5, 2026)
Bedrock Robotics | $270,000,000 | (Feb 5, 2026)
Fibr AI | $7,500,000 | (Feb 5, 2026)
Expert Intelligence™ | $4,700,000 | (Feb 5, 2026)
Positron AI | $230,000,000 | (Feb 5, 2026)
Chamber(US) | $60,000,000 | (Feb 5, 2026)
SENAI | $6,200,000 | (Feb 5, 2026)
OneDome | $25,000,000 | (Feb 4, 2026)
Naoma AI | $440,000 | (Feb 4, 2026)